moxifloxacin has been researched along with dolutegravir in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (dolutegravir) | Trials (dolutegravir) | Recent Studies (post-2010) (dolutegravir) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 1,128 | 179 | 1,105 |
| Protein | Taxonomy | moxifloxacin (IC50) | dolutegravir (IC50) |
|---|---|---|---|
| Chain A, PFV integrase | Human spumaretrovirus | 0.0517 | |
| Chain A, PFV integrase | Human spumaretrovirus | 0.0517 | |
| Chain A, PFV integrase | Human spumaretrovirus | 0.0517 | |
| Solute carrier family 22 member 2 | Homo sapiens (human) | 1.9 | |
| Integrase | Human immunodeficiency virus 1 | 0.0414 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borland, J; Chen, S; Fujiwara, T; Lou, Y; Min, SS; Peppercorn, A; Piscitelli, SC; Song, I | 1 |
1 trial(s) available for moxifloxacin and dolutegravir
| Article | Year |
|---|---|
Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aza Compounds; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Follow-Up Studies; Heart Conduction System; Heterocyclic Compounds, 3-Ring; HIV Integrase Inhibitors; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Oxazines; Piperazines; Pyridones; Quinolines; Socioeconomic Factors; Young Adult | 2012 |